
Opinion|Videos|April 1, 2025
Quality of Life Impact: Supporting Patients With GPP
Panelists discuss how generalized pustular psoriasis (GPP) profoundly impacts patients’ quality of life through physical pain, psychological distress, social isolation, and functional limitations, necessitating comprehensive support systems that address both medical management and psychosocial well-being.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Expanding Oral JAK Inhibitor Options for Children With AD and Alopecia Areata
3
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
4
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
5












